Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

F Stock Is a Lot Better Than It Looks After Last Week’s Earnings

By Chris Lau, InvestorPlace Contributor

F stock benefits from an upcoming launch of dozens of new products, ranging from SUVS to full-electric vehicles.

MMM Stock Is Poised to Grow From Strong Protective Gear Demand

By Chris Lau, InvestorPlace Contributor

MMM stock rose after a strong quarterly report, as it continues to benefit from strong mask and personal protective equipment demand.

Why Aurora Cannabis Is Focusing Sharply on Costs

By Chris Lau, InvestorPlace Contributor

Expect continued volatility with ACB stock as the company lowers costs and manages supply to match demand.

Nio Is Looking to Catch Up With Tesla in China

By Chris Lau, InvestorPlace Contributor

Nio stock formed an uptrend after the company posted strong March deliveries, giving investors hope that its sales will grow.

7 5G Stocks That Still Look Strong

By Chris Lau, InvestorPlace Contributor

Investors have seven stocks to buy from in the 5G space that will out-perform the markets regardless of the economic turmoil ahead.

Load More